Market Overview:
The global automatic chemiluminescence immunoassay analyzer market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for rapid and accurate diagnostic tests, technological advancements in chemiluminescence immunoassay analyzers, and rising prevalence of chronic diseases. Based on type, the global automatic chemiluminescence immunoassay analyzer market is segmented into enhanced chemiluminescence and chemiluminescence. The enhanced chemiluminescence segment is expected to grow at a higher CAGR than the chemiluminescence segment during the forecast period from 2018 to 2030. This growth can be attributed to the increasing demand for advanced diagnostic tests that offer high accuracy and precision. Based on application, the global automatic chemiluminescence immunoassay analyzer market is divided into hospitals, clinics, and others (laboratories/research institutes). The hospitals segment accounted for a major share of the global automatic ChemLumin ImmunoAssays Analyzers Market in 2017 owing to rising incidence of chronic diseases such as cancer and diabetes mellitus which require regular monitoring through laboratory tests.
Product Definition:
An automatic chemiluminescence immunoassay analyzer is a machine that is used to measure the amount of a specific protein in blood. This machine is important because it can help doctors to quickly and accurately diagnose diseases.
Enhanced Chemiluminescence:
Enhanced Chemiluminescence Immunoassay (ECLAIA) is a technology that enhances the chemiluminescence immunoassay by improving its sensitivity, selectivity & accuracy. It utilizes micro-electro-mechanical system (MEMS) technology to measure analytes in complex biological fluids such as urine, serum, plasma and tissue samples with high precision and within shorter time intervals.
Chemiluminescence:
Chemiluminescence Immunoassay (CLIA) is a technique used for the detection of biological molecules such as proteins, nucleic acids, and chemical compounds. It utilizes light energy to detect these targets in samples. Chemiluminescence immunoassay analyzer market is expected to witness lucrative growth over the forecast period owing to increasing demand for automation in healthcare industry coupled with rising prevalence of chronic diseases globally.
Application Insights:
The others application segment dominated the global automatic chemiluminescence immunoassay analyzer market in 2017. This is attributed to the presence of a large number of unmet medical needs that cannot be addressed through conventional laboratory tests. The hospital segment is expected to grow at a lucrative rate over the forecast period owing to an increase in demand for rapid, sensitive and specific diagnostic tests.
Conventional blood testing methods are time-consuming and require several days before providing results. These factors have led to an increased adoption of point-of-care devices that can provide accurate results within minutes at a significantly lower cost than conventional laboratories.
Regional Analysis:
North America dominated the global arena in 2017. The region is expected to maintain its position during the forecast period owing to high demand for technologically advanced medical devices and increasing prevalence of chronic diseases. In addition, presence of well-established healthcare facilities and favorable reimbursement policies are also contributing towards market growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising geriatric population, improving healthcare infrastructure, growing awareness about chemiluminescence immunoassay analyzers among physicians & patients as well as government agencies & non-government organizations (NGOs). Moreover, economic development coupled with rapid urbanization has led to improvement in living standards which has resulted into increased demand for various types of diagnostic tests from developing countries such as India and China.
Growth Factors:
- Increasing demand for rapid and accurate diagnostic tests
- Technological advancements in the field of immunoassay analyzers
- Growing prevalence of chronic diseases that require frequent monitoring
- Rising number of hospitals and clinics that offer immunoassay testing services
- Increasing awareness about the benefits of early diagnosis and treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Automatic Chemiluminescence Immunoassay Analyzer Market Research Report
By Type
Enhanced Chemiluminescence, Chemiluminescence
By Application
Hospitals, Clinics, Others
By Companies
Roche Diagnostics, Abbott, Danaher, Siemens Healthcare, Johnson & Johnson, Snibe, DiaSorin, Luminex Corporation, Leadman Biochemistry, Maccura, Autobio Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Automatic Chemiluminescence Immunoassay Analyzer Market Report Segments:
The global Automatic Chemiluminescence Immunoassay Analyzer market is segmented on the basis of:
Types
Enhanced Chemiluminescence, Chemiluminescence
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abbott
- Danaher
- Siemens Healthcare
- Johnson & Johnson
- Snibe
- DiaSorin
- Luminex Corporation
- Leadman Biochemistry
- Maccura
- Autobio Diagnostics
Highlights of The Automatic Chemiluminescence Immunoassay Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Enhanced Chemiluminescence
- Chemiluminescence
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Automatic Chemiluminescence Immunoassay Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An Automatic Chemiluminescence Immunoassay Analyzer (ACIA) is a laboratory instrument that uses chemiluminescence to measure the levels of specific proteins in a sample.
Some of the major companies in the automatic chemiluminescence immunoassay analyzer market are Roche Diagnostics, Abbott, Danaher, Siemens Healthcare, Johnson & Johnson, Snibe, DiaSorin, Luminex Corporation, Leadman Biochemistry, Maccura, Autobio Diagnostics.
The automatic chemiluminescence immunoassay analyzer market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Automatic Chemiluminescence Immunoassay Analyzer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Automatic Chemiluminescence Immunoassay Analyzer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Automatic Chemiluminescence Immunoassay Analyzer Market - Supply Chain
4.5. Global Automatic Chemiluminescence Immunoassay Analyzer Market Forecast
4.5.1. Automatic Chemiluminescence Immunoassay Analyzer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Automatic Chemiluminescence Immunoassay Analyzer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Automatic Chemiluminescence Immunoassay Analyzer Market Absolute $ Opportunity
5. Global Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Type
5.3.1. Enhanced Chemiluminescence
5.3.2. Chemiluminescence
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Automatic Chemiluminescence Immunoassay Analyzer Demand Share Forecast, 2019-2026
9. North America Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Type
9.7.1. Enhanced Chemiluminescence
9.7.2. Chemiluminescence
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Automatic Chemiluminescence Immunoassay Analyzer Demand Share Forecast, 2019-2026
10. Latin America Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Type
10.7.1. Enhanced Chemiluminescence
10.7.2. Chemiluminescence
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Automatic Chemiluminescence Immunoassay Analyzer Demand Share Forecast, 2019-2026
11. Europe Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Automatic Chemiluminescence Immunoassay Analyer Market Size and Volume Forecast by Type
11.7.1. Enhanced Chemiluminescence
11.7.2. Chemiluminescence
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Automatic Chemiluminescence Immunoassay Analyzer Demand Share, 2019-2026
12. Asia Pacific Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Type
12.7.1. Enhanced Chemiluminescence
12.7.2. Chemiluminescence
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Automatic Chemiluminescence Immunoassay Analyzer Demand Share, 2019-2026
13. Middle East & Africa Automatic Chemiluminescence Immunoassay Analyzer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Automatic Chemiluminescence Immunoassay Analyzer Market Size and Volume Forecast by Type
13.7.1. Enhanced Chemiluminescence
13.7.2. Chemiluminescence
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Automatic Chemiluminescence Immunoassay Analyzer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Automatic Chemiluminescence Immunoassay Analyzer Market: Market Share Analysis
14.2. Automatic Chemiluminescence Immunoassay Analyzer Distributors and Customers
14.3. Automatic Chemiluminescence Immunoassay Analyzer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Snibe
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. DiaSorin
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Luminex Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Leadman Biochemistry
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Maccura
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Autobio Diagnostics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
